These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Concomitant chemoradiotherapy of infiltrating cancers of the bladder]. Housset M Cancer Radiother; 1998 Dec; 2(6):713-7. PubMed ID: 9922778 [TBL] [Abstract][Full Text] [Related]
8. Gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer: Long-term cumulative results of 2 prospective single-institution studies. Caffo O; Fellin G; Graffer U; Mussari S; Tomio L; Galligioni E Cancer; 2011 Mar; 117(6):1190-6. PubMed ID: 20960501 [TBL] [Abstract][Full Text] [Related]
9. The current status of bladder preservation in the treatment of muscle invasive bladder cancer. Kim HL; Steinberg GD J Urol; 2000 Sep; 164(3 Pt 1):627-32. PubMed ID: 10953112 [TBL] [Abstract][Full Text] [Related]
10. Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review. Koga F; Kihara K Int J Urol; 2012 May; 19(5):388-401. PubMed ID: 22409269 [TBL] [Abstract][Full Text] [Related]
11. Hypofractionated intensity modulated radiation therapy in combined modality treatment for bladder preservation in elderly patients with invasive bladder cancer. Turgeon GA; Souhami L; Cury FL; Faria SL; Duclos M; Sturgeon J; Kassouf W Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):326-31. PubMed ID: 24411604 [TBL] [Abstract][Full Text] [Related]
12. Treatment strategies using transurethral surgery, chemotherapy, and radiation therapy with selection that safely allows bladder conservation for invasive bladder cancer. Kanady KE; Shipley WU; Zietman AL; Kaufman DS; Althausen AF; Heney NM Semin Surg Oncol; 1997; 13(5):359-64. PubMed ID: 9259092 [TBL] [Abstract][Full Text] [Related]
13. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684 [TBL] [Abstract][Full Text] [Related]
14. Trimodalities for bladder cancer in elderly: Transurethral resection, hypofractionated radiotherapy and gemcitabine. Mohamed HAH; Salem MA; Elnaggar MS; Gabr A; Abdelrheem AM Cancer Radiother; 2018 May; 22(3):236-240. PubMed ID: 29678595 [TBL] [Abstract][Full Text] [Related]
15. The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer. Asadauskiene J; Aleknavicius E; Pipiriene-Zelviene T; Jankevicius F Medicina (Kaunas); 2010; 46(5):305-14. PubMed ID: 20679745 [TBL] [Abstract][Full Text] [Related]
16. Gemcitabine and cisplatin as neoadjuvant chemotherapy for invasive transitional and squamous cell carcinoma of the bladder: effect on survival and bladder preservation. Khaled HM; Shafik HE; Zabhloul MS; Ghoneim M; Saber RA; Manie M; Enein HA; Megeed HA; Mansur O; Sherbini ME; Mahran TZ; Kalawee ME; Badran A; Ramadan SM Clin Genitourin Cancer; 2014 Oct; 12(5):e233-40. PubMed ID: 24889794 [TBL] [Abstract][Full Text] [Related]